LSIA
SGMO

LaSalle St. Investment Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

LaSalle St. Investment Advisors’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.74K Buy
+19,200
New +$7.64K ﹤0.01% 410
2025
Q4 		– Sell
-19,200
Closed -$12K – 389
2025
Q3 		$12K Buy
+19,200
New +$10.4K ﹤0.01% 354
2025
Q2 		– Sell
-19,200
Closed -$12K – 347
2025
Q1 		$12K Buy
+19,200
New +$20.3K ﹤0.01% 318

Other funds holding SGMO

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

LaSalle St. Investment Advisors's SGMO Position: Q1 2026 in Review

LaSalle St. Investment Advisors opened a new position in SANGAMO THERAPEUTICS INC (SGMO) in Q1 2026: 19,200 shares worth $4.74K. The stake represents ﹤0.01% of the portfolio and ranks #410 among its holdings. This is a return to the name: LaSalle St. Investment Advisors previously reported a position in SGMO as recently as Q3 2025.

LaSalle St. Investment Advisors first reported a position in SGMO in Q1 2025 and has held it in 3 quarters since. The position peaked at $12K in Q3 2025. 112 funds tracked by Wall St. Rank hold SGMO as of Q1 2026.

  • LaSalle St. Investment Advisors held 19,200 shares of SANGAMO THERAPEUTICS INC worth $4.74K as of Q1 2026.
  • SANGAMO THERAPEUTICS INC was a new LaSalle St. Investment Advisors position in Q1 2026.
  • SANGAMO THERAPEUTICS INC made up ﹤0.01% of LaSalle St. Investment Advisors's portfolio in Q1 2026, its #410 holding.
  • LaSalle St. Investment Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q1 2025 and has held it in 3 quarters since.
  • LaSalle St. Investment Advisors's SANGAMO THERAPEUTICS INC position peaked at $12K in Q3 2025.
  • 112 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2026.

Based on LaSalle St. Investment Advisors's 13F filing for Q1 2026, filed 8 May 2026.